Back to Search Start Over

A Phase II Open-Label, Single-arm Clinical Trial to Study the Safety, Efficacy and Pharmacokinetics of MK-3009 (Daptomycin) in Japanese Pediatric Participants Aged 1 to 17 Years With cSSTI or Bacteremia Caused by Gram-positive Cocci

A Phase II Open-Label, Single-arm Clinical Trial to Study the Safety, Efficacy and Pharmacokinetics of MK-3009 (Daptomycin) in Japanese Pediatric Participants Aged 1 to 17 Years With cSSTI or Bacteremia Caused by Gram-positive Cocci

Source :
Pharma Business Week. September 10, 2018, 141
Publication Year :
2018

Abstract

2018 SEP 10 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Staff editors report on the newly launched clinical trial, NCT03643952, which has the following [...]

Details

Language :
English
ISSN :
15436675
Database :
Gale General OneFile
Journal :
Pharma Business Week
Publication Type :
News
Accession number :
edsgcl.553547434